Abstract
Introduction

1
Mushroom-forming Basidiomycota fungi are known to be prolific producers of structurally 2 diverse, bioactive natural products (NPs) and have been used since ancient times in traditional 3 medicine (1). This group of fungi is particularly known for their terpenoid NPs, which appear to be 4 the major class of NPs produced by them (1, 2). Well-known examples of pharmaceutically 5 relevant terpenoid-derived compounds include the widely used livestock antibiotic pleuromutilin 6 (3), the anticancer compound illudin S (4), the melleolide antibiotics (5) , and the nerve growth 7 factor-synthesis promoting erinacines (6) (Figure 1 ). The 1000 fungal genomes project performed 8 by the Joint Genome Institute (JGI) (7) has resulted in a large influx of Basidiomycota genome 9 sequences and genomic data from hundreds of Basidiomycota taxa that can now be searched in 10 silico for NP biosynthetic gene clusters.
12
However, despite their incredible potential for NP discovery, Basidiomycota fungi are a largely 13 unexplored territory for drug discovery compared to Ascomycota fungi. While an abundance of 14 genetic tools and techniques for transformation and genetic manipulation are available for yeast and 15 filamentous fungi, such methods are mostly lacking for Basidiomycota fungi (2, 8). In addition, 16
many Basidiomycota strains are difficult to grow under laboratory conditions, requiring the 17 determination of suitable growth conditions and often long fermentation times. Characterization of 18 their biosynthetic genes therefore typically requires heterologous expression in a more genetically 19 tractable host. Unfortunately, Basidiomycota have very intron-rich genomes and genes that contain 20 very small and unpredictable exons, especially in cytochrome P450 monooxygenase genes, that 21 currently necessitate the amplification of genes from cDNA. Even if a gene is expressed, alternative 22 splice variants may be produced that are not functional (2). All pioneering works to access the large 23 diversity of terpenoid NPs made by Basidiomycota have therefore relied on the amplification of 24 functional terpene synthase (TS) genes from cDNA for expression and characterization in E. coli or 25 yeasts, limiting the complete functional analysis of all computationally identified TSs in 26
Basidiomycota genomes (9) (10) (11) (12) (13) . Being able to directly express Basidiomycota biosynthetic genes 27 from genomic DNA in a suitable fungal surrogate host would therefore greatly accelerate the 28 functional characterization of NP pathways. 29 30 We reasoned that a genetically tractable Ascomycota could potentially be used as a heterologous 31 host for the functional expression of Basidiomycota NP biosynthetic genes. Unlike yeasts, which 32 have relatively few genes with introns, a splicing machinery of filamentous fungi such as 33
Aspergillus is more similar to that of Basidiomycota (14) . Heterologous expression of biosynthetic 34 genes from filamentous fungi directly from genomic DNA has become a powerful approach to 35 elucidate biosynthetic pathways. We have used this strategy with the Ascomycota Aspergillus 36 oryzae (AO) for the heterologous production of several NPs and their pathway intermediates 37 (15-18) and to access difficult to obtain pathway intermediates for the study of intriguing enzyme 38 reactions (19-21). Recently, we successfully produced in AO the Basidiomycota-derived diterpene 39 pleuromutilin from cDNA amplified biosynthetic genes. Like others, we found the cloning of 40 functional genes from Basidiomycota cDNA to be difficult and tedious. We and others also showed 41 that the native AO NADPH cytochrome P450 reductase supports the activity of the Basidiomycota 1 P450 monooxygenases pathway (22, 23). Given our success with using AO for the direct expression 2 of fungal NP biosynthetic genes from genomic DNA and the ability of AO to functionally express a 3 Basidiomycota terpenoid NP biosynthetic enzymes, including its P450 monooxygenase, we 4 therefore hypothesized that this Ascomycota would make an excellent platform strain for the 5 characterization and production of Basidiomycota NP pathways, in particular its terpenoid 6 pathways. 7 8
Here, we describe a new strategy using AO as an expression host for the heterologous 9 production of Basidiomycota NP biosynthetic genes. We selected two different terpenoid classes 10 (pleuromutilin diterpene and sesquiterpenoids) from two different Basidiomycota and performed a 11 systematic analysis of the predicted and experimentally obtained splicing patterns in AO. Our 12 results indicated that a significant fraction of genes was correctly spliced by AO, while many 13 partially spliced genes could be corrected based on gene model predictions and functionally 14 expressed in AO.
16
Results and Discussion 17
Expression of pleuromutilin biosynthetic genes from genomic DNA in Aspergillus oryzae 18
We previously achieved the heterologous production of the Basidiomycota diterpene 19 pleuromutilin using an A. oryzae expression system (22). Therefore, we initially examined the 20 heterologous expression of pleuromutilin biosynthetic genes using genomic DNA sequences in this 21
Ascomycota host. When we tested the gene expression of GGPP synthase ple4 and terpene synthase 22 ple3 in A. oryzae, the resultant transformant (TF) successfully produced premutilin (1) (Figure 2 ).
23
Sequencing of cDNA sequences recovered from the TF AO-ple3/4 showed that all introns (ple3/4: 24 3/4) were correctly spliced ( Figure 2 ). We next examined the expression of intron rich P450 genes 25 (ple1/5/6: 10/13/11). cDNA sequence analysis showed that all 11 introns of ple6 were successfully 26 spliced while ple1/5 each contained one unspliced introns (ple1: intron-6 out of 10; ple5: intron-4 27 out of 13), which can be readily removed by PCR-based methods. Based on these promising results, 28
we speculated that gene splicing in Basidiomycota resembles that of Ascomycota fungi (14, 24) .
Functional gene expression analysis of STS genes 31
Given that almost all introns of ple genes were successfully spliced in AO, we next performed a 32 comprehensive analysis of Basidiomycota gene expression from genomic DNA in this host. To 33 establish the versatility of Basidiomycota heterologous expression using AO, we chose to test the 34 expression of sesquiterpene synthases (STSs) because they are prolific in Basidiomycota genomes 35 and are small enzymes that convert abundant farnesyl pyrophosphate (FPP) in host cells into 36 various cyclic, volatile products that can be readily identified by GC-MS analysis of cultures (25).
37
In this work, we selected 31 STS genes for characterization from two Basidiomycota fungi, our 38 pleuromutilin producer C. pseudo-pinsitus and for comparison, Stereum hirsutum which was 39 previously investigated for sesquiterpenoid production (11) (Figure 3 , Table S1 ). 40 41
STSs from Clitopilus pseudo-pinsitus 1
Our Local-Blast search using aristolochene synthase as a query sequence identified 18 STS 2 candidate genes (CpSTS1-18) in C. pseudo-pinsitus ( Figure 3 , Table S1 ). Open reading frames 3 (ORFs) were manually predicted by comparison with functionally characterized fungal STS genes. 4
Except for CpSTS10, which lacked the conserved motifs (DDXXD; NSE) of STSs, 17 ORFs were 5 selected for expression in AO. To ensure the expression of target genes, we used the recently 6 developed fungal CRISPR-Cas9 system specifically optimized for AO (26) . In the presence of the 7 CRISPR/Cas9 plasmid with the protospacer sequence for the SC103 locus, which was found in a 8 strain that produced betaenone in good yield (27) , ligD-deficient A. oryzae NSPlD1 (28) was 9 transformed using a donor DNA plasmid carrying a targeted STS gene. Usually, the knock-in rate 10 ranged from 80 to 90%, much higher than in normal random integrations. GC-MS analysis of 11 headspace volatiles from these TFs revealed that nine AO TFs expressed functional STS that 12 cyclized FPP into the cyclic products (Figures 3, S1 , and S2). Sesquiterpenes were identified by 13 retention indices (RI) and comparison of MS fragmentation patterns with those reported in 14 databases or the literature ( Figure S1 and and Table S2 ). Only CpSTS15 did not give any product although all introns were likely spliced 24 correctly. 25
Sesquiterpenes produced by CpSTSs include 1) aromadendrene type sesquiterpenes featuring 26 the 5-7-3 tricyclic skeleton, such as ledene (2) and virifloridol (3) (C1,C10-cyclization products) 27 ( Figure 3b ), 2) structurally unique sesquiterpenes such as 6-protoilludene (7), sterpurene (8), 28 pentalenene (9), and -caryophyllene (10) (C1,C11-cyclization products) (Figure 3c ), 3) cadinene 29 type sesquiterpenes possessing the 6-6 bicyclic structure, such as -cadinene (12) and -muurolene, 30
and biosynthetically related ones such as -cubebene (13) (C1,C10-cyclization products) (Figures 31 3e and S2), and 4) linear and monocyclic sesquiterpenes such as -farnesene (11) and -elemene 32 (Figures 3c and S2 ). Among them, 7 and cadinenes are frequently isolated from fungi and the 33 corresponding STSs have been functionally characterized (2). By contrast, 8 produced by CpSTS1 34 is known as a fungi specific sesquiterpene and a sterpurene synthase has not been identified.
35
Successful functional characterization of CpSTS1 enabled us to search putative sterpurene 36 synthases in public database and identify homologs in Psilocybe cyanescens (72%, PPQ78014.1), 37
Gymnopilus dilepis (72%, PPQ64797.1), and Fibularhizoctonia sp. CBS 109695 (66%, 38 KZP33092.1) although 8 and the related metabolites have not been isolated from them. 39 Table S3 ) (30), possibly arising by gene duplication of ancestral STS, a well known 9 evolutionary mechanism in this class of fungi (31). These STSs produced the aromadendrene family 10 members and aristolene (6) , which are frequently found as plant volatiles (Figures 3b and S4 ), but 11 only one corresponding STS from Citrus (CsSesquiTPS5) has been characterized (32). All of them 12 are most likely biosynthesized via bicyclogermacrene (IM1) (30, 32-34). These results suggested a 13 strong relationship of the gene structure and the cyclization mechanism. It should be emphasized 14 that comprehensive analysis of 17 STSs provides direct evidence regarding the gene structure and 15 the enzyme function. 16 17
STSs from S. hirsutum 18
Previously, 18 STS genes were bioinformatically predicted in the mushroom S. hirsutum and 19 five STS genes were successfully amplified from cDNA for functional expression in E. coli (11, 35) .
20
The remaining STS were not studied, partially because of cDNA availability limitations. We sought 21 this suite of STS from S. hirsutum would be another good test system for our direct gene expression 22 strategy. Of the 18 STS genes (ShSTS1-18), we excluded five genes from our study to avoid the 23 expression of ShSTS2/9/14/15/6 that showed >60% homology to ShSTS1/8/13/16 and CpSTS3 24 (Table S4) . GC-MS analysis of culture headspace showed that seven AO TFs expressing 25 (ShSTS-1/4/7/8/11/16/17) produced sesquiterpenes such as 7, 12, 15, -barbatene, and hirsutene, 26 (Figures 3, S1, S2 and Table S2 ). As in the case of CpSTSs, sequencing of cDNA showed intron 27 skipping at one (ShSTS5/12/13/18) or two positions (ShSTS3/10) ( Figure 3d ). Removal of 28 predicted introns in ShSTS3/5/10/12/13/18 gave functional STSs in E. coli transformants that 29 synthesized terpenes such as 10, 11, 13, 14, 16, and -cadinene (Figures 3, S1, S2 and Table S2 ).
30
The metabolite profiles revealed that clade III ShSTSs as well as those of CpSTSs produce 31 structurally unique sesquiterpene such as 7-10 as a single product while other STSs appear to give 32 multiple biosynthetically related products. 33 34
A strong correlation between gene structure and function was also found in Stereum TSs; clade 35 II ShSTS8/9/10/11/12 revealed a relatively high sequence identity (>48%) and the gene structures 36 of ShSTS10/11/12 are nearly identical, whereas that of the ShSTS8 gene is likely modified by the 37 insertion of an extra intron (Figures 3d and 4) . These STSs generated cadinene-type sesquiterpenes 38 biosynthesized via Z,E-germacrenedienyl cation (IM2) (Figure 3e ). In addition, a conservation of 39 sequence identity (>54%) and gene structure is observed for clade III ShSTSs, ShSTS15/16/17/18 40 ( Figures 3c and 4) , which produce 7 as a characteristic and major sesquiterpene made by 41 mushrooms. The gene structure of ShSTS13 resembles with those of Clade III ShSTSs except that 1 an extra N-terminal intron is inserted (Figure 3d ). The structural difference between 7 2 (ShSTS15/16/17/18) and 10 (ShSTS13) might reflect to alter the transition states derived from 3 common intermediate IM3. When we searched for putative biosynthetic gene clusters surrounding 4
clade II and III Cp-and Sh-STS paralogs/orthologs, we found quite divergent arrangements of 5 putative biosynthetic genes for modifying terpene scaffold ( Figure S5 ). 6 7
Splicing of Basidiomycota genes in AO. 8
To gain insights into the splicing patterns of Basidiomycota genes in AO, we analyzed the 9 sequences of spliced and nonspliced introns of genes investigated in this study (Table S3) Figure S3 ), demonstrating that 20 introns in Basidiomycota genes that are recognized for splicing are faithfully and reliably spliced by 21 AO. Intron skipping tends to occur at one or two positions in STS genes. A similar pattern was 22 observed for pleuromutilin genes investigated in this work (Figure 2 ). 23
Estimation of reliability for computational prediction of introns and ORFs 24
Comparison of the cDNA sequences of the large number of 30 functional STS sequences 25 characterized in this work with computationally predicted gene structures provides an excellent 26 assessment of the reliability of bioinformatics tools such as Augustus (29) for Basidiomycota gene 27 prediction (Tables S3 and S5 CpSTS8 and ShSTS11 ( Figure 5 ). Most errors concerning ORFs and introns located close to the 35 3'-terminal end of the genes (example iv) can be avoided by manual prediction by considering the 36 amino acid sequences of the known STSs and the gene structures of paralogous STS genes ( Figure  37 3). Therefore, automated prediction may be useful when these measures are taken. Actually, we 38 used Augustus prediction when we needed to remove nonspliced intron(s) in the AO expression. We 39 successfully used this strategy to identify and subsequently remove nonspliced introns by AO in 40 recovered cDNA for expression of active STS by EC-TFs (F1). Consequently, direct expression of 1
Basidiomycota genes from genomic DNA in AO in conjunction with bioinformatics proved to be an 2 effective and reliable strategy to quickly obtain functional NP biosynthetic genes. 3 4
Concluding remarks 5
In this work we developed an efficient approach for heterologous expression of Basidiomycota 6 NP biosynthetic genes directly from genomic DNA in the genetically tractable and well-studied 7
Asocomycota host A. oryzae. We show that direct expression of unspliced genes from genomic 8 DNA from Basdiomycota in AO results in almost correctly spliced introns and that a combination of 9 computational and manual gene structure prediction can be used to identify and correct nonspliced 10 introns in recovered cDNA by a quick PCR step. Out of 30 STS expressed in AO using this method, Accession number: The sequences of sesquiterpene synthase genes found in C. pseudo-pinsitus 8 ATCC20527 have been deposited in the DNA Data Bank of Japan (DDBJ). The accession numbers 9 are summarized in Table S1 . 10 11
Construction of A. oryzae expression plasmids of ple and sesquiterpene synthase genes.
12
Pleuromutin biosynthetic genes (ple13456) were amplified from the genomic DNA of C. 13 pseudo-pinsitus ATCC20527 (22) with primer set as shown in Supplemental Table S6 . Each PCR 14 product was inserted into appropriate restriction site (site 1 and/or site 2) of pDP1031 or pDP1032 15 to construct the following expression plasmids; pDP1031-ple5 (KpnI site), pDP1032-ple6 (NheI 16 site), pDP1032-ple3 (KpnI)/4 (SpeI), and pDP1032-ple7 (KpnI)-ple1 (SpeI).
17
Sesquiterpene synthase genes were amplified from the genomic DNA of C. pseudo-pinsitus 18 ATCC20527 and S. hirsutum FP-91666 S1 (11) with primer set as shown in Supplemental Table S6 .
19
Each PCR product was then inserted into the appropriate restriction sites of expression vectors to 20 construct the following expression plasmids; pTAex3-CpSTS1, pUARA2-CpSTS2, 21 pUARA2-CpSTS3, pTAex3-CpSTS4, pDP1031-CpSTS5, pDP1031-CpSTS6, pDP1031-CpSTS7, 22 pDP1031-CpSTS8, pDP1031-CpSTS9, pDP1031-CpSTS10, pDP1031-CpSTS11, 23 pDP1031-CpSTS12, pUSA2-CpSTS13, pDP1031-CpSTS14, pDP1031-CpSTS15, pUSA2-CpSTS16, 24 pDP1031-CpSTS17, pDP1031-CpSTS18, pDP1032-ShSTS1/18, pDP1031-ShSTS3, 25 pDP1031-ShSTS4, pDP1031-ShSTS5, pDP1031-ShSTS7, pDP1031-ShSTS8, pDP1031-ShSTS10, 26 pDP1032-ShSTS11/16, pDP1031-ShSTS12, pDP1031-ShSTS13, and pDP1031-ShSTS17. Protoplasting was performed using Yatalase (Takara; 5.0 mg mL -1 ) in Solution 1 (0.8 mM of NaCl, 35 10 mM of NaH2PO4, pH 6.0) at 30 °C for 2 h. Protoplasts were centrifuged at 2,000 rpm (Beckman 36 JLA10.500) for 5 min and washed with 0.8 M of NaCl solution. Then, protoplasts were adjusted to 37 2.0 x 10 8 cells/mL by adding Solution 2 (0.8 M of NaCl, 10 mM of CaCl2, 10 mM of Tris-HCl, pH 38 8.0) and Solution 3 (40 % (w/v) of PEG4000, 50 mM of CaCl2, 50 mM of Tris-HCl, pH 8.0) in 4/1 39 volume ratio. To the protoplast solution (200 L) was added a cas9 plasmid (2 g) and a donor 40 plasmid (5 g). The aliquot was incubated on ice for 20 min and then Solution 3 (1 mL) added to 41 the aliquot. After 20 min incubation at room temperature, Solution 2 (10 mL) added to the mixtures 1 and the mixture was centrifuged at 2,000 rpm (Beckman JLA10.500) for 5 min. After decantation, 2 the residue was diluted with Solution 2 (500 L) and the mixture (100 L) was poured onto the 3 CD agar plate (1.5 %) supplemented with 4.7% of NaCl and then overlaid with the soft-top CD agar 4 (0.6 %) containing 21.8 % of sorbitol. The plates were incubated at 30 °C for 3-7 days. 5 6
Analysis of the metabolites from AO-transformants harboring a STS gene. Mycelia of each 7 transformant was inoculated into a MPY medium (1 mL) containing 20 mM of uridine and 0.2% of 8 uracil in 10 mL test tube. Each culture was incubated at 30 °C for 4 days. The volatile organic 9 compounds were extracted by a SPME fiber (50/30 um DVB/CAR/PDMS. Stableflex, 24Ga, 10
Manual Holder), which was conditioned by inserting it into the GC injector to prevent contamination, 11 during 30 min at room temperature. After extraction, the fiber was pulled into the needle sheath and 12 the SPME device was removed from the vial and then inserted into the injection port of a GC-MS 13 QP2010 apparatus (Shimadzu, Kyoto, Japan) with a HP-5 capillary column (0.32 mm × 30 m, 0.25 14 m film thickness; J&W Scientific, Folsom, CA). Each sample was injected onto the column at 15 60 °C in the splitless mode. The column temperature was increased by 4 °C min -1 to 180 °C. The 16 flow rate of the helium carrier gas was 0.66 mLmin -1 (method A).
18
Isolation of sesquiterpenes.
19
Sterpurene; Mycelia of AO-CpSTS1 were inoculated into a solid medium containing polished rice 20 (100 g) and adenine (10 mg) in 500 mL Erlenmeyer flasks. Each culture was incubated at 30 °C for 21 12 days. After extraction with ethyl acetate, the extract was concentrated in vacuo to afford crude 22 extracts. The crude extracts were purified with silica gel column chromatography (hexane) to give 23 sterpurene (20.0 mg from 1.3 kg of rice medium from AO-CpSTS1). The NMR data are in good 24 agreement with the reported data ( Figure S6, 41 ). synthesized with PrimeScriptTM II 1st strand cDNA synthesis kit (Takara) using the oligo dT 37 primer according to the manufacturer's instructions. The cDNA was used as a template of the PCR 38 reactions for direct sequencing and subcloning of each STS gene into the pColdI vector. 39 40
Estimation of sequences of functionally active STSs. cDNA sequences derived from AO 41 transformant were aligned with the predicted sequence by Augustus for identifying the nonspliced 42 introns in cDNA sequences. Alignments were computed by using ClustalW. The resultant 1 transcripts of putative intronless STSs were then manually examined for the presence of and proper 2 alignment of the conserved motifs characteristic for sesquiterpene synthases. 3 4
Construction of E. coli expression plasmids. Intronless DNA clone was prepared from PCR-based 5 removal of the nonspliced introns (Figures 3 and 4) as follows; two DNA fragments (upstream-and 6 downstream regions of the nonspliced intron) were separately amplified from cDNA with primer set 7 as shown in Supplemental Table S6 . Each PCR product was inserted into NdeI-, EcoRI-, or 8
KpnI-digested pColdI to construct the following expression plasmids; pColdI-CpSTS5, 9
pColdI-CpSTS7, pColdI-CpSTS8, pColdI-CpSTS13, pColdI-CpSTS14, pColdI-CpSTS16, 10 pColdI-CpSTS17, pColdI-ShSTS3, pColdI-ShSTS5, pColdI-ShSTS10, pColdI-ShSTS12, 11 pColdI-ShSTS13, and pColdI-ShSTS18. 12 13
Analysis of the metabolites from EC-transformants. The constructed plasmids were separately 14 introduced into E. coli BL21-Gold(DE3) for overexpression. The transformant was grown at 37 °C 15
at an OD600 of ~0.6 in 500 mL flask. After cooling at 4 °C, isopropyl -D-thiogalactopyranoside 16 (0.1 mM) was added to the culture. After incubation at 16 °C for 17 h, the volatile organic 17 compounds were extracted by a SPME fiber (50/30um DVB/CAR/PDMS. 
